23andMe

Ancestry answered the DNA questions 23andMe couldn’t

A really awesome thing about being black is that ancestry can be very unclear because of, you know, slavery. Enter DNA kits.

23andMe confirms $250 million round led by Sequoia

Genetics testing company 23andMe has formally announced that Sequoia Capital is leading an investment round in the company. This confirms the news we broke last week.  The press release says that the

23andMe’s second act sits squarely in drug research and development

The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders f

Equity podcast: Roku is going public, 23andMe raises $200M and Juicero is dead

Hello and welcome back to Equity, TechCrunch’s venture capital-themed podcast. This week Matthew Lynley, Katie Roof, and myself — Alex! — sat down with Micah Rosenbloom, an investo

23andMe hits $1.5B pre-money valuation in latest huge funding round

Following up on the news of 23andMe’s huge upcoming financing round, TechCrunch has learned that the company is raising the new financing at a $1.5 billion pre-money valuation. This compares to

23andMe is raising about $200 million, led by Sequoia

23andMe, the Mountain View-based genetic testing and analysis company, is raising close to $200 million in a funding round led by Sequoia Capital, multiple sources tell us. Sources say that Fidelity i

TechCrunch Disrupt SF 2017 will feature some of tech’s wildest success stories

TechCrunch Disrupt SF 2017 is less than a month away at Pier 48 in San Francisco. This year's lineup includes a stellar group of speakers, including Pinterest's Ben Silbermann, Golden State Warriors s

Color Genomics goes beyond cancer with a test for heart health

Cancer and heart disease are the two leading causes of death in the United States. So far, Color Genomics has been focused on testing for mutations leading to a higher risk of certain cancers. But, to

Modern Fertility is offering a comprehensive fertility test for women who hope to be moms someday

There are a number of ways to find out more about your fertility these days -- including from several at-home fertility test startups that have started to pop up in the last few years. Modern Fertili

23andMe’s Anne Wojcicki is speaking at Disrupt SF

Discovering your heritage is just a spit-tube away these days, thanks to the pioneering efforts 23andMe, the OG of at-home DNA tests. The decade-old company forged the path towards consumer access to

EverlyWell rolls out three new DNA-based products for food sensitivity, metabolism and breast milk

There's a lot going on in commercial DNA testing these days beyond what eye color you have or where your mitochondria comes from, and at-home lab testing startup EverlyWell hopes to cash in. The start

Doggie DNA startup Embark raises $4.5 million in seed to find your puppy’s breed

Ever wanted to know the genetic mix of your mutt? Embark, a doggie DNA startup has raised $4.5 million in seed to expand its offering of genetic kits for your pup’s pedigree. Embark launched in

9 promising at-home lab test startups for everything from fertility to STDs

It’s easier than ever to skip the doctor and go straight for the at-home test these days, thanks to updated regulations and the technology to match — and for many, it’s the answer to

Crunch Report | Jeff Bezos Sells $1B in Amazon Stock Annually to Fund Blue Origin

The Kriesel high-performance electric converted Porsche, Jeff Bezos sells $1 billion in stock annually to fund Blue Origin, Hyperloop One completes Vegas test track and 23andMe can now let you know if

23andMe is finally allowed to tell you if you have the genes for Parkinson’s

The Food and Drug Administration finally gave 23andMe a long sought-after green light today to sell to consumers genetic tests and their accompanying health risk reports for up to 10 diseases, includi

Advances in AI and ML are reshaping healthcare

The application of AI/ML in healthcare is reshaping the industry and making what was once impossible into a tangible reality.

23andMe reportedly no longer working on next-gen sequencing

23andMe won’t continue with next-generation DNA sequencing and has reportedly laid off the lab working on the project. About half-a-dozen workers were laid off from the Salt Lake City, Utah-base

Color Genomics raises $45 million to provide cheaper genetic tests that detect cancer risk

Othman Laraki and Elad Gil were sitting on Twitter’s roof deck after their previous company Mixer Labs had been acquired. Gil had brought a small hard drive with him — which happened to contai

23andMe’s Anne Wojcicki has a plan to include better genetic data from people of color

One of the first consumer genetic testing companies, 23andMe says it aims to be at the forefront in gathering genetically diverse data throughout the world. The company just launched a standalone $99

Innovation in genomics and the future of medtech 

The field of medicine is in the process of being profoundly transformed by new technologies; much of this transformation comes from exciting advances in genomics. Although genomics is relatively unkno
Load More